Cultured Blood Dendritic Cells Retain HIV-1 Antigen-Presenting Capacity for Memory CTL during Progressive HIV-1 Infection

Journal of Immunology

Volumn 159, Issue 10, 1997, Pages 4973-4982

  Fan, Zheng ^a   Huang, Xiao Li ^a   Zheng, Lian ^a   Wilson, Cara ^b   Borowski, Luann ^a   Liebmann, James ^a   Gupta, Phalguni ^a   Margolick, Joseph ^c   Rinaldo, Charles ^a,b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; OLIGOPEPTIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIGEN PRESENTATION; ARTICLE; BLOOD; CELL CULTURE; CELL SEPARATION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; DISEASE COURSE; DRUG EFFECT; HISTOCOMPATIBILITY TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; SERODIAGNOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIGEN PRESENTATION; CELL SEPARATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; DISEASE PROGRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HIV ANTIGENS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; OLIGOPEPTIDES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031573052     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Steinman, R. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
2. Galy, A., M. Travis, D. Cen, and B. Chen. 1995. Human T, B, natural killer, and dendritic cells arise from a common hone marrow progenitor cell subset. Immunity 3:459.
3. Caux, C., B. Vanbervliet, C. Massacrier, M. Azuma, K. Okumura, L. L. Lanier, and J. Banchereau. 1994. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J. Exp. Med. 180: 1841.
4. Lanier, L. L., S. O'Fallon, C. Somoza, J. H. Phillips, P. S. Linsley, K. Okumura, D. Ito, and M. Azuma. 1995. CD80 (B7) and CD86 (B70) provide similar co-stimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 154:97.
5. + T cells. J. Immunol. 154:5071.
6. Kang, K., M. Kubin, K. D. Cooper, S. R. Lessin, G. Trinchieri, and A. H. Rook. 1996. IL-12 synthesis by human Langerhans cells. J. Immunol. 156:1402.
7. Heufler, C., F. Koch, U. Stanzl, G. Topar, M. Wysocka, G. Trinchieri, A. Enk, R. M. Steinman, N. Romani, and G. Schuler. 1996. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur. J. Immunol. 26:659.
8. Ghanekar, S., L. Zheng, A. Logar, J. Navratil, L. Borowski, P. Gupta, and C. Rinaldo. 1996. Cytokine expression by human peripheral blood dendritic cells stimulated in vitro with HIV-1 and herpes simplex virus. J. Immunol. 157:4028.
9. + blood dendritic cells are potent producers of IFN-α in response to in vitro HIV-1 infection. J. Immunol. 152:4649.
10. Lanzavecchia, A. 1996. Mechanisms of antigen uptake for presentation. Curr. Opin. Immunol. 8:348.
11. Belsito, D. V., M. R. Sanchez, R. L. Baer, F. Valentine, and G. J. Thorbecke. 1984. Reduced Langerhans' cell 1a antigen and ATPase activity in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 310:1279.
12. Eales, L. J., J. Farrant, M. Helbert, and A. J. Pinching. 1988. Peripheral blood dendritic cells in persons with AIDS and AIDS related complex: loss of high intensity class II antigen expression and function. Clin. Exp. Immunol. 71:423.
13. Macatonia, S. E., S. Patterson, and S. C. Knight. 1989. Suppression of immune responses by dendritic cells infected with HIV. Immunology 67:285.
14. Macatonia, S. E., R. Lau, S. Patterson, A. J. Pinching, and S. C. Knight. 1990. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 71:38.
15. Macatonia, S. E., S. Patterson, and S. C. Knight. 1991. Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells. Immunologv 74:399.
16. Macatonia, S. E., M. Gompels, A. J. Pinching, S. Patterson, and S. C. Knight. 1992. Antigen-presentation by macrophages but not by dendritic cells in human immunodeficiency virus (HIV) infection. Immunology 75:576.
17. Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. D. Fritsch, R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83.
18. Peters, J. H., R. Gieseler, B. Thiele, and F. Steinbach. 1996. Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunol. Today 17:273.
19. Rinaldo, C., X. L. Huang, Z. Fan, M. Ding, L. Beltz, A. Logar, D. Panicali, G. Mazzara, J. Liebmann, M. Cottrill, and P. Gupta. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69:5838.
20. Huang, X. L., Z. Fan, J. Liebmann, and C. Rinaldo. 1995. Detection of human immunodeficiency virus type 1-specific memory cytotoxic T lymphocytes in freshly donated and frozen-thawed peripheral blood mononuclear cells. Clin. Diagn. Lab. Immunol. 2:678.
21. Croft, M. 1994. Activation of naive, memory and effector T cells. Curr. Opin. Immunol. 6:431.
22. Kaslow, R. A., D. G. Ostrow, R. Detels, J. P. Phair, B. F. Polk, and C. R. Rinaldo, Jr. 1987. The Multicenter AIDS Cohort Study: rationale, organization and selected characteristics of the participants. Am. J. Epidemiol. 126:310.
23. Giorgi, J. V., H. L. Cheng, J. B. Margolick, K. D. Bauer, J. Ferbas, M. Waxdal, I. Schmid, L. E. Hultin, A. L. Jackson, L. Park, and J. M. G. Taylor. 1990. Quality control in the flow cytometric measurement of T-lymphocyte subsets: the Multicenter AIDS Cohort Study experience. Clin. Immunol. Immunopathol. 55:173.
24. Gupta, P., M. Ding, M. Cottrill, C. Rinaldo, L. Kingsley, S. Wolinsky, and J. Mellors. 1995. Quantitation of human immunodeficiency virus type 1 DNA and RNA by a novel internally controlled PCR assay. J. Clin. Microbiol. 33:1670.
25. Thiele, D. L., and P. E. Lipsky. 1986. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes. J. Immunol. 136:1038.
26. McMichael, A., and B. Walker. 1994. Cytotoxic T lymphocyte epitopes: implications for HIV vaccines. AIDS 8:S155.
27. Fazekas de St. Groth, S. 1982. The evaluation of limiting dilution assays. J. Immunol. Methods 49:R11.
28. Ferbas, J., J. Navratil, A. Logar, and C. Rinaldo. 1995. Selective decrease in human immunodeficiency virus type 1 (HIV-1)-induced alpha interferon production by peripheral blood mononuclear cells during HIV-1 infection. Clin. Diagn. Lab. Immunol. 2:138.
29. Chollet-Martin, S., G. Pialoux, and A. Gougerot-Pocidalo. 1988. Increased CD1-positive cells in peripheral blood of AIDS and ARC patients. Immunol. Lett. 17:53.
30. + patients. Clin. Immunol. Immunopathol. 70:190.
31. + T cells. Science 257: 383.
32. Canque, B., M. Rosenzwajg, S. Camus, M. Yagello, M.-L. Bonnet, M. Guigon, and J. C. Gluckman. 1996. The effect of in vitro human immunodeficiency virus infection on dendritic-cell differentiation and function. Blood 88:4215.
33. Kanitakis, J., C. Marchand, H. Su, J. Thivolet, G. Zambruno, D. Schmitt, and L. Gazzolo. 1989. Immunohistochemical study of normal skin of HIV-1-infected patients shows no evidence of infection. AIDS Res. Hum. Retroviruses 5:293.
34. Kalter, D. C., J. J. Greenhouse, J. M. Orenstein, S. M. Schnittman, H. E. Gendelman, and M. S. Meltzer. 1991. Epidermal Langerhans cells are not principal resenoirs of virus in HIV disease. J. Immunol. 146:3396.
35. + T cells. J. Clin. Invest. 1994:797.
36. Jondal, M., R. Schirmbeck, and J. Reimann. 1996. MHC class I-restricted CTL responses to exogenous antigens. Immunity 5:295.
37. Tsai, V., S. Southwood, J. Sidney, K. Sakaguchi, Y. Kawakami, E. Appella, A. Sette, and H. Celis. 1997. Identification of subdominant CTL epitopes of the gp100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic colls. J. Immunol. 158:1796.
38. Sercarz, E. E., P. V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729.
39. + CTLs from naive precursors. J. Immunol. 153:996.
40. Dupuis, M., M. V. Peshwa, C. Benike, S. K. Kundu, E. G. Engleman, W. C. A. Van Schooten, and T. C. Merigan. 1997. Allogeneic dendritic cell induction of HIV-specific cytotoxic T lymphocyte responses from T cells of HIV type 1-infected and uninfected individuals. AIDS Res. Hum. Retroviruses 13:33.
41. Cella, M., F. Sallusto, and A. Lanzavecchia. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9:10.
42. Blauvelt, A., M. Clerici, D. R. Lucey, S. M. Steinberg, R. Yarchoan, R. Walker, G. M. Shearer, and S. I. Katz. 1995. Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons. J. Immunol. 154:3506.
43. Carmichael, A., X. Jin, P. Sissons, and L. Borysiewicz. 1993. Quantitative analysis of the human immunodeficiency virus type (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249.
44. Klein, M. R., C. A. van Baalen, A. M. Holwerda, S. R. Kerkhof Garde, R. J. Bende, I. P. Keet, J. K. Eeftinck-Schattenkerk, A. D. Osterhaus, H. Schuitemaker, and F. Miedema. 1995. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1365.
45. Wolinsky, S. M., B. T. M. Korber, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsel, M. R. Furtado, Y. Cao, D. D. Ho, J. T. Safrit, and R. A. Koup. 1996. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537.
46. Haynes, B. F., G. Pantalco, and A. S. Fauci. 1996. Toward an understanding of the correlates of protective immunity to HIV infection. Science 271:324.
47. Fidler, S. J., I. Dorrell, S. Ball, G. Lombardi, J. Weber, C. Hawrylowicz, and A. D. Rees. 1996. An early antigen-presenting cell defect in HIV-1-infected patients correlates with CD4 dependency in human T-cell clones. Immunology 89:46.
48. Knight, S. C., S. Patterson, and S. E. Macatonia. 1991. Stimulatory and suppressive effects of infection of dendritic cells with HIV-1. Immunol. Lett. 30:213.
49. Knight, S. C., S. E. Macatonia, and S. Patterson. 1993. Infection of dendritic cells with HIV-1: virus load regulates stimulation and suppression of T-cell activity. Res. Virol. 144:75.
50. O'Doherty, U., M. Peng, S. Gezelter, W. J. Swiggard, M. Betjes, N. Bhardwaj, and R. M. Steinman. 1994. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 82:487.
51. Weissman, D., Y. Li, J. Ananworanich, L. J. Zhou, J. Adelsberger, T. F. Tedder, M. Baseler, and A. S. Fauci. 1995. Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 92:826.
52. Girolomoni, G., and P. Ricciardi-Castagnoli. 1997. Dendritic cells hold promise for immunotherapy. Immunol. Today 18:102.
53. Mayordomo, J. I., T. Zorina, W. J. Storkus, L. Zitvogel, C. Celluzzi, L. D. Falo, C. J. Melief, S. T. Ildstad, W. M. Kast, A. B. DeLeo, and M. T. Lotze. 1995. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med. 1:1297.
54. Celluzzi, C. M., J. I. Mayordomo, W. J. Storkus, M. T. Lotze, and L. D. Falo, Jr. 1996. Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med. 183:283.
55. + cytotoxic T lymphocytes. Eur. J. Immunol. 26:2595.
56. Shen, Z., G. Reznikoff, G. Dranoff, and K. L. Rock. 1997. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158:2723.
57. Boczkowski, D., S. K. Nair, D. Snyder, and E. Gilboa. 1996. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 184:465.
58. Condon, C., S. C. Watkins, C. M. Celluzzi, K. Thompson, and L. D. Falo, Jr. 1996. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2:1122.